HEM Pharma Inc. (KOSDAQ:376270)
South Korea
· Delayed Price · Currency is KRW
59,500
-1,500 (-2.46%)
At close: Apr 28, 2026
HEM Pharma Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 |
| Apr '26 Apr 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
| Market Capitalization | 426,983 | 327,494 | 114,874 |
| Market Cap Growth | 165.50% | 185.09% | - |
| Enterprise Value | 432,682 | 334,986 | - |
| Last Close Price | 59500.00 | 45850.00 | 16500.00 |
| PS Ratio | 32.90 | 25.23 | 7.62 |
| PB Ratio | 81.88 | 62.80 | 4.40 |
| P/TBV Ratio | 121.00 | 92.81 | 4.54 |
| EV/Sales Ratio | 33.34 | 25.81 | - |
| Debt / Equity Ratio | 3.69 | 3.69 | 0.30 |
| Net Debt / Equity Ratio | 1.05 | 1.05 | -0.13 |
| Net Debt / EBITDA Ratio | -0.42 | -0.42 | 0.66 |
| Net Debt / FCF Ratio | -0.30 | -0.30 | 0.28 |
| Asset Turnover | 0.29 | 0.29 | - |
| Inventory Turnover | 9.97 | 9.97 | - |
| Quick Ratio | 0.38 | 0.38 | 1.73 |
| Current Ratio | 0.56 | 0.56 | 1.91 |
| Return on Equity (ROE) | -151.43% | -151.43% | - |
| Return on Assets (ROA) | -21.96% | -21.96% | - |
| Return on Capital Employed (ROCE) | -137.30% | -137.30% | -27.60% |
| Earnings Yield | -5.58% | -7.28% | -6.66% |
| FCF Yield | -4.24% | -5.53% | -10.77% |
| Buyback Yield / Dilution | -10.69% | -10.69% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.